In cancer cells, higher levels of c-Myc expression drives increased transcription and activity of key glycolytic enzymes, including lactate dehydrogenase (LDH) and hexokinase 2 (HK2) (14, 42, 78, 80, 81). Here, HK2 is linked to cancer.